erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
the medical experts are worse. their pretense of idealism knows no limits, and is matched only by their claim to bullet-proof knowledge..
our view: parents who don’t vaccinate put others in peril.